Skip to main content

Table 7 Frequency of virulence genes among antibiotic-resistant E. coli isolates

From: Phenotypic and molecular characterizations of multidrug-resistant diarrheagenic E. coli of calf origin

Antibiotic resistance (beef and dairy cattle)

Beef cattle E. coli carry virulence genes

n (%)

Dairy cattle E. coli carry virulence genes

n (%)

Irp2

fyuA

Stx1

F41

hylA

eaeA

Irp2

fyuA

F41

Stx1

eaeA

K99

STa

PEN

28/43

27/43

10/43

7/43

1/43

1/43

6/27

6/27

4/27

1/27

1/27

1/27

1/27

(43) and (27)

65.1%

62.8%

23.3%

16.9%

0.02%

0.02%

22.2%

22.2%

14.8%

3.7%

3.7%

3.7%

3.7%

AMC

18/24

13/24

4/24

7/24

0/24

0/24

6/22

5/22

4/22

1/22

1/22

1/22

1/22

(24) and (22)

75%

54.2%

16.7%

25.9%

0%

0%

27.3%

22.7%

18.2%

0.05%

0.05%

0.05%

0.05%

AMP

25/38

22/38

7/38

7/38

1/38

1/38

6/26

5/26

4/26

1/22

1/22

1/22

1/22

(38) and (26)

65.8%

57.9%

18.4%

18.4%

0.03%

0.03%

23.1%

19.2%

15.4%

0.05%

0.05%

0.05%

0.05%

CFZ

17/21

11/21

3/21

7/21

0/21

0/21

4/19

4/19

4/19

1/22

1/22

1/22

1/22

(21) and (19)

80.9%

52.4%

14.3%

33.3%

0%

0%

21.1%

21.1%

21.1%

0.05%

0.05%

0.05%

0.05%

STR

16/22

12/22

4/22

7/20

0/18

0/18

4/18

4/18

4/18

1/22

1/22

1/22

1/22

(22) and (18)

72.7%

54.5%

18.2%

35%

0%

0%

22.2%

22.2%

22.2%

0.05%

0.05%

0.05%

0.05%

GEN

16/20

11/20

4/20

6/20

0/20

0/20

3/17

2/17

0/17

0/17

0/17

0/17

0/17

(20) and (17)

80%

55%

20%

30%

0%

0%

17.6%

11.8%

0%

0%

0%

0%

0%

KAN

14/19

11/19

4/19

6/19

0/19

0/19

2/12

2/12

3/12

0/12

0/12

1/22

1/22

(19) and (12)

73.7%

57.9%

21.1%

31.6%

0%

0%

16.7%

16.7%

25%

0%

0%

0.05%

0.05%

TET

22/31

17/31

7/31

7/31

1/31

1/31

6/21

5/21

4/21

1/21

1/21

1/21

1/21

(31) and (21)

70.9%

54.8%

22.6%

22.6%

0.03%

0.03%

28.6%

23.8%

19%

0.05%

0.05%

0.05%

0.05%

COM

18/26

14/26

4/26

7/26

0/26

0/26

5/21

5/21

4/21

1/21

1/21

1/21

1/21

(26) and (21)

69.2%

53.8%

15.9%

26.9%

0%

0%

23.8%

23.8%

19%

0.05%

0.05%

0.05%

0.05%

SULF

20/30

16/30

5/30

7/30

1/30

1/30

6/22

6/22

4/22

1/22

1/22

1/22

1/22

(30) and (22)

66.7%

53.3%

16.7%

23.3%

0.03%

0.03%

27.3%

27.3%

18.2%

0.05%

0.05%

0.05%

0.05%

CIP

18/22

12/22

4/22

6/22

0/22

0/22

4/18

3/18

4/18

0/18

1/18

1/18

1/18

(22) and (18)

81.8%

54.5%

18.2%

27.3%

0%

0%

22.2%

16.7%

22.2%

0%

0.06%

0.06%

0.06%

ENR

18/23

12/23

4/23

7/23

0/23

0/23

4/17

3/17

3/17

1/17

0/17

1/17

1/17

(23) and (17)

78.3%

52.1%

17.4%

30.4%

0%

0%

23.5%

17.6%

17.6%

0.06%

0%

0.06%

0.06%

OFX

17/19

13/19

4/19

6/19

0/19

0/19

3/17

3/17

3/17

0/17

0/17

0/17

0/17

(19) and (17)

89.5%

68.4%

21.1%

31.6%

0%

0%

17.6%

17.6%

17.6%

0%

0%

0%

0%

FFC

12/17

7/17

2/17

7/17

0/17

0/17

2/9

2/9

1/9

1/9

1/9

0/9

0/9

(17) and (9)

70.6%

41.2%

11.8%

41.2%

0%

0%

22.2%

22.2%

11.1%

11.1%

11.1%

0%

0%

PB

0/1

1/1

0/1

0/1

0/1

0/1

0/0

0/0

0/0

0/0

0/0

0/0

0/0

(1) and (0)

0%

100%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

  1. Note: β-lactams: penicillin (PEN), amoxicillin (AMC), ampicillin (AMP), and cefazolin (CFZ); aminoglycosides: streptomycin (STR), gentamicin (GEN), and kanamycin (KAN); tetracyclines: tetracycline (TET); sulfonamides: compound sulfamethoxydiazine (SULF); fluoroquinolones: ciprofloxacin (CIP), enrofloxacin (ENR), and ofloxacin (OFX); chloramphenicol: florfenico (FFC); polypeptides: polymyxin B (PB)